Tech Company Financing Transactions
CAGE Bio Funding Round
CAGE Bio closed a $7.2 million Series A venture capital round on 2/17/2021. Investors included private investors.
Transaction Overview
Company Name
Announced On
2/17/2021
Transaction Type
Venture Equity
Amount
$7,200,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
733 Industrial Rd.
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Website
Email Address
Overview
CAGE Bio Inc., currently a resident company at Johnson & Johnson Innovation, JLABS MBC BioLabs, is a clinical-stage startup exploiting its proprietary deep eutectic ionic liquid platform to develop novel products for dermatology, inflammation, and immunology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Ravi Srinivasan
Chief Executive Officer
Nitin Joshi
Co-Founder
Samir Mitragotri
Browse more venture capital transactions:
Prev: 2/17/2021: Realm Home venture capital transaction
Next: 2/17/2021: Iterion Therapeutics venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs